ARTICLE | Clinical News
SCY-078: Interim Phase II data
August 15, 2016 7:00 AM UTC
Interim data from 22 evaluable patients with invasive candidiasis who were initially treated with IV echinocandin in an open-label, international Phase II trial showed that oral SCY-078 was well toler...